Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (603) 603
humans (577) 577
female (351) 351
male (332) 332
middle aged (268) 268
surgery (262) 262
aged (230) 230
adult (220) 220
infectious diseases (200) 200
risk factors (158) 158
intraabdominal infections (156) 156
microbiology (153) 153
retrospective studies (153) 153
anti-bacterial agents - therapeutic use (140) 140
mortality (133) 133
epidemiology (132) 132
health aspects (125) 125
treatment outcome (124) 124
management (123) 123
pharmacology & pharmacy (108) 108
antibiotics (103) 103
aged, 80 and over (101) 101
medicine & public health (97) 97
microbial sensitivity tests (95) 95
anti-bacterial agents - pharmacology (94) 94
risk-factors (91) 91
abdomen (89) 89
adolescent (89) 89
intraabdominal infections - microbiology (89) 89
analysis (87) 87
prospective studies (86) 86
sepsis (86) 86
infections (82) 82
intraabdominal infections - drug therapy (79) 79
complicated intraabdominal infections (78) 78
intraabdominal infections - epidemiology (78) 78
postoperative complications - epidemiology (78) 78
peritonitis (75) 75
young adult (73) 73
incidence (72) 72
care and treatment (69) 69
research (68) 68
abridged index medicus (67) 67
prognosis (62) 62
drug resistance (59) 59
escherichia-coli (59) 59
child (58) 58
gastroenterology & hepatology (58) 58
enterobacteriaceae (57) 57
hospitals (57) 57
klebsiella-pneumoniae (57) 57
diagnosis (54) 54
drug resistance, bacterial (54) 54
bacteria (53) 53
critical care medicine (53) 53
critically-ill patients (52) 52
guidelines (49) 49
intensive care units (49) 49
internal medicine (49) 49
infectious disease (46) 46
intensive-care-unit (46) 46
time factors (46) 46
double-blind (45) 45
prevalence (45) 45
septic shock (45) 45
therapy (45) 45
patients (44) 44
appendicitis (42) 42
children (42) 42
drug resistance in microorganisms (42) 42
pediatrics (42) 42
abdominal surgery (41) 41
outcomes (41) 41
abscess (40) 40
cross infection - microbiology (40) 40
intra-abdominal infection (40) 40
pneumonia (40) 40
susceptibility (40) 40
antimicrobial agents (39) 39
antimicrobial resistance (39) 39
intraabdominal infection (39) 39
child, preschool (38) 38
gram-negative bacilli (38) 38
intraabdominal hypertension (38) 38
medicine, general & internal (38) 38
nosocomial infections (38) 38
pseudomonas-aeruginosa (38) 38
bacterial infections - drug therapy (37) 37
enterobacteriaceae - drug effects (37) 37
gram-negative bacteria (37) 37
intensive care (37) 37
medical research (37) 37
multivariate analysis (37) 37
appendicitis - surgery (36) 36
in-vitro activity (36) 36
prevention (36) 36
antibiotic-therapy (35) 35
blood-stream infections (35) 35
complications (35) 35
drug resistance, multiple, bacterial (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (669) 669
Spanish (11) 11
German (5) 5
French (4) 4
Chinese (3) 3
Hungarian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text High prevalence of hypervirulent Klebsiella pneumoniae infection in China: Geographic distribution, clinical characteristics, and antimicrobial resistance
by Zhang, Yawei and Zhao, Chunjiang and Wang, Qi and Wang, Xiaojuan and Chen, Hongbin and Li, Henan and Zhang, Feifei and Li, Shuguang and Wang, Ruobing and Wang, Hui
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6115 - 6120
Hypervirulent Klebsiella pneumoniae (hvKP) is traditionally defined by hypermucoviscosity, but data based on genetic background are limited.... 
STRAINS | AEROBACTIN | VIRULENCE ANALYSIS | TAIWAN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | HONG-KONG | EMERGENCE | PYOGENIC LIVER-ABSCESS | Diabetes Mellitus - pathology | Prevalence | Prospective Studies | Klebsiella Infections - pathology | Humans | Middle Aged | Virulence | Male | Klebsiella pneumoniae - classification | Phylogeny | Multilocus Sequence Typing | Cross Infection - pathology | beta-Lactamases - genetics | Pneumonia, Bacterial - pathology | Gene Expression | Pneumonia, Bacterial - complications | Plasmids - metabolism | Cross Infection - microbiology | Diabetes Mellitus - epidemiology | Plasmids - chemistry | Bacteremia - epidemiology | Bacteremia - pathology | Neoplasms - epidemiology | Intraabdominal Infections - complications | Klebsiella pneumoniae - isolation & purification | Diabetes Complications | Cross Infection - complications | Bacteremia - microbiology | Neoplasms - complications | Klebsiella Infections - epidemiology | Klebsiella pneumoniae - genetics | Adult | Female | beta-Lactamases - metabolism | Cross Infection - epidemiology | Pneumonia, Bacterial - microbiology | Intraabdominal Infections - microbiology | Neoplasms - microbiology | Phylogeography | Bacteremia - complications | Bacterial Proteins - genetics | Serogroup | Klebsiella Infections - complications | Pneumonia, Bacterial - epidemiology | China - epidemiology | Klebsiella Infections - microbiology | Intraabdominal Infections - epidemiology | Diabetes Mellitus - microbiology | Intraabdominal Infections - pathology | Klebsiella pneumoniae - pathogenicity | Bacterial Proteins - metabolism | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: Report from an antimicrobial surveillance programme (2012-15)
by Pfaller, Michael A and Bassetti, Matteo and Duncan, Leonard R and Castanheira, Mariana
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1386 - 1395
Objectives: To evaluate the in vitro activity of ceftolozane/tazobactam and comparators tested against European isolates of Enterobacteriaceae and Pseudomonas... 
INFECTIOUS DISEASES | HOSPITALS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PREVALENCE | BLOOD-STREAM INFECTIONS | Penicillanic Acid - pharmacology | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Humans | Europe - epidemiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Intraabdominal Infections - epidemiology | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Urinary Tract Infections - epidemiology | Epidemiological Monitoring | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Israel - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - drug effects | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Cephalosporins - pharmacology | Penicillanic Acid - analogs & derivatives | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)
by Lu, Po-Liang and Liu, Yung-Ching and Toh, Han-Siong and Lee, Yu-Lin and Liu, Yuag-Meng and Ho, Cheng-Mao and Huang, Chi-Chang and Liu, Chun-Eng and Ko, Wen-Chien and Wang, Jen-Hsien and Tang, Hung-Jen and Yu, Kwok-Woon and Chen, Yao-Shen and Chuang, Yin-Ching and Xu, Yingchun and Ni, Yuxing and Chen, Yen-Hsu and Hsueh, Po-Ren
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2012, Volume 40, Issue 1, pp. S37 - S43
Summary In 2009, the Study for Monitoring Antimicrobial Resistance Trends (SMART) was expanded to include surveillance of Gram-negative pathogens causing... 
Infectious Disease | Asia-Pacific region | Fluoroquinolone resistance | Urinary tract infections | Extended-spectrum β-lactamase (ESBL) | SMART | Carbapenems | Interpretive susceptibility criteria | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | Extended-spectrum beta-lactamase (ESBL) | INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | BACILLI | Penicillanic Acid - pharmacology | Prevalence | Prospective Studies | Ceftazidime - pharmacology | Humans | Australasia - epidemiology | Drug Resistance, Bacterial | Amikacin - pharmacology | beta-Lactamases - biosynthesis | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacteria - enzymology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Asia - epidemiology | Piperacillin - pharmacology | beta-Lactams - pharmacology | Carbapenems - pharmacology | Gram-Negative Bacteria - pathogenicity | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Penicillanic Acid - analogs & derivatives | Moxalactam | Levofloxacin | Pneumonia | Bacterial pneumonia | Disease susceptibility | Antibacterial agents | Cephalosporins | Beta lactamases | Cephaloridine | Bacteria | Cross infection | Nosocomial infections | Ciprofloxacin | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Epidemiology and trends in the antibiotic susceptibilities of Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region, 2010–2013
by Chang, Ya-Ting and Coombs, Geoffrey and Ling, Thomas and Balaji, V and Rodrigues, Camilla and Mikamo, Hiroshige and Kim, Min-Ja and Rajasekaram, Datin Ganeswrie and Mendoza, Myrna and Tan, Thean Yen and Kiratisin, Pattarachai and Ni, Yuxing and Barry, Weinman and Xu, Yingchun and Chen, Yen-Hsu and Hsueh, Po-Ren
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2017, Volume 49, Issue 6, pp. 734 - 739
Highlights • Epidemiology and susceptibility patterns of intra-abdominal infection isolates in the Asia-Pacific region from 2010–2013. • Amikacin, ertapenem... 
Infectious Disease | Gram-negative bacilli | Antimicrobial susceptibility | Intra-abdominal infection | Asia-Pacific region | Epidemiology | Extended-spectrum β-lactamase | INFECTIOUS DISEASES | PIPERACILLIN-TAZOBACTAM | ESCHERICHIA-COLI | CARBAPENEMASES | MICROBIOLOGY | Extended-spectrum beta-lactamase | CEFEPIME | BACTEREMIA | ANTIMICROBIAL RESISTANCE TRENDS | PHARMACOLOGY & PHARMACY | AMPC BETA-LACTAMASES | SMART | PROGRAM | ENTEROBACTERIACEAE | Prospective Studies | Intraabdominal Infections - microbiology | Humans | Drug Resistance, Bacterial | Gram-Negative Bacteria - isolation & purification | Intraabdominal Infections - epidemiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Asia - epidemiology | Pacific Islands - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Abscess | Beta lactamases | Disease susceptibility | Health aspects | Antibacterial agents | Abdomen | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals
by Zhang, Jing and Zheng, Beiwen and Zhao, Lina and Wei, Zeqing and Ji, Jinru and Li, Lanjuan and Xiao, Yonghong
BMC Infectious Diseases, ISSN 1471-2334, 12/2014, Volume 14, Issue 1, pp. 659 - 659
Background: In order to investigate the epidemiology, molecular characteristics, and distribution of extended-spectrum beta-lactamase (ESBL)- and... 
SPECTRUM-BETA-LACTAMASE | ANTIMICROBIAL SUSCEPTIBILITY | MOLECULAR CHARACTERIZATION | UNITED-STATES | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | EXTENDED-SPECTRUM | GENOTYPE DISTRIBUTION | INTRAABDOMINAL INFECTIONS | KLEBSIELLA-PNEUMONIAE | Prevalence | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Male | Multilocus Sequence Typing | Young Adult | beta-Lactamases - genetics | Bacterial Typing Techniques | Polymerase Chain Reaction | Aged, 80 and over | Adult | DNA, Bacterial - analysis | Female | beta-Lactamases - metabolism | Escherichia coli - enzymology | Bacterial Proteins - genetics | Escherichia coli Infections - microbiology | Hospitals, County | Escherichia coli Proteins - metabolism | Genotype | China - epidemiology | Genetic Markers | Sequence Analysis, DNA | Escherichia coli Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Adolescent | Escherichia coli Proteins - genetics | Bacterial Proteins - metabolism | Aged | Community-Acquired Infections - microbiology | Escherichia coli - classification | Hospitals | Escherichia coli | Beta lactamases | Cross infection | Nucleotide sequencing | Nosocomial infections | Health aspects | Epidemiology | Prevalence studies (Epidemiology) | DNA sequencing | Studies | Bacterial infections | Antibiotics | E coli | Laboratories | Antimicrobial agents | Drug resistance | Medical diagnosis | Bacteriology | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: Evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections
by Koksal, Iftihar and Yilmaz, Gurdal and Unal, Serhat and Zarakolu, Pinar and Korten, Volkan and Mulazimoglu, Lutfiye and Tabak, Fehmi and Mete, Birgul and Oguz, Vildan Avkan and Gulay, Zeynep and Alp, Emine and Badal, Robert and Lob, Sibylle
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1364 - 1372
Objectives: To describe the epidemiology and susceptibility of pathogens (including ESBL producers) from hospital-acquired (HA) versus community-acquired (CA)... 
RESISTANCE TRENDS SMART | UNITED-STATES | INFECTIOUS DISEASES | ASIA-PACIFIC REGION | EASTERN-EUROPE | MICROBIOLOGY | IN-VITRO SUSCEPTIBILITIES | ANTIMICROBIAL RESISTANCE | DISEASES SOCIETY | GRAM-NEGATIVE BACILLI | CHILDREN GUIDELINES | SURVEILLANCE | PHARMACOLOGY & PHARMACY | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Enterobacteriaceae - isolation & purification | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Carbapenems - pharmacology | Escherichia coli - pathogenicity | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Intensive Care Units | Intraabdominal Infections - microbiology | Enterobacteriaceae - pathogenicity | Amikacin - pharmacology | Imipenem - pharmacology | Intraabdominal Infections - epidemiology | Urinary Tract Infections - epidemiology | beta-Lactams - pharmacology | Turkey - epidemiology | Escherichia coli - isolation & purification | Klebsiella pneumoniae - pathogenicity | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Acute infections and venous thromboembolism
by Schmidt, M and Horvath‐Puho, E and Thomsen, R. W and Smeeth, L and Sørensen, H. T
Journal of Internal Medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
Schmidt M, Horvath‐Puho E, Thomsen RW, Smeeth L, Sørensen HT (Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital,... 
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | CONTROLLED-TRIAL | HOSPITALIZED-PATIENTS | RISK-FACTORS | LOW-DOSE HEPARIN | FATAL PULMONARY-EMBOLISM | PREVENTION | DEEP-VEIN THROMBOSIS | MEDICINE, GENERAL & INTERNAL | INFARCTION | COMMUNITY | MEDICAL PATIENTS | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia
by Ong, David S. Y and Bonten, Marc J. M and Safdari, Khatera and Spitoni, Cristian and Frencken, Jos F and Witteveen, Esther and Horn, Janneke and Klein Klouwenberg, Peter M. C and Cremer, Olaf L and de Beer, Friso M and Bos, Lieuwe D. J and van Hooijdonk, Roosmarijn T. M and Huson, Mischa A and Schouten, Laura R. A and Straat, Marleen and van Vught, Lonneke A and Wiewel, Maryse A and Glas, Gerie J and Wieske, Luuk and Schultz, Marcus J and van der Poll, Tom and MARS Consortium and MARS consortium
Clinical infectious diseases, ISSN 1058-4838, 2015, Volume 61, Issue 9, pp. 1413 - 1420
Enterococcal bacteremia has been associated with high case fatality, but it remains unknown to what extent death is caused by these infections. We therefore... 
mortality | bloodstream infection | intensive care unit | enterococcus | bacteremia | DIAGNOSIS | INFECTIOUS DISEASES | MICROBIOLOGY | IMMUNOLOGY | ATTRIBUTABLE MORTALITY | INTRAABDOMINAL INFECTION | NOSOCOMIAL INFECTIONS | DISEASES SOCIETY | MULTISTATE MODELS | INTENSIVE-CARE-UNIT | POPULATION-BASED ASSESSMENT | CRITICALLY-ILL PATIENTS | BLOOD-STREAM INFECTIONS | Intensive Care Units | Prospective Studies | Humans | Middle Aged | Mortality | Netherlands - epidemiology | Bacteremia - drug therapy | Cross Infection - mortality | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Bacteremia - diagnosis | Gram-Positive Bacterial Infections - diagnosis | Cross Infection - drug therapy | Gram-Positive Bacterial Infections - epidemiology | Enterococcus - isolation & purification | Aged, 80 and over | Cross Infection - diagnosis | Adult | Bacteremia - epidemiology | Female | Aged | Gram-Positive Bacterial Infections - drug therapy | Cross Infection - epidemiology | Enterococcus | Intensive care units | Care and treatment | Analysis | Research | Management | Epidemiology | Bacteremia | Gram-positive bacteria | Fatalities | Intensive care | Bacterial infections | Disease management | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
by Lob, Sibylle H and Hoban, Daryl J and Sahm, Daniel F and Badal, Robert E
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2016, Volume 47, Issue 4, pp. 317 - 323
Highlights • Acinetobacter baumannii susceptibility varied by geographic region but was low everywhere. • Resistance increased over time in several regions. •... 
Infectious Disease | Acinetobacter baumannii | Surveillance | Susceptibility | Multidrug resistance | INFECTIOUS DISEASES | INFECTIONS | INTENSIVE-CARE UNITS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | SURVEILLANCE TRIAL | PNEUMONIA | AFRICA | PHARMACOLOGY & PHARMACY | TIGECYCLINE EVALUATION | IN-VITRO ACTIVITY | EPIDEMIOLOGY | MIDDLE-EAST | Global Health | Intraabdominal Infections - microbiology | Humans | Intraabdominal Infections - epidemiology | Urinary Tract Infections - epidemiology | Hospitals | Acinetobacter Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Acinetobacter Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Resistance mechanisms and epidemiology of multiresistant pathogens in europe and efficacy of tigecycline in observational studies
by Heizmann, Wolfgang R and Dupont, Hervé and Montravers, Philippe and Guirao, Xavier and Eckmann, Christian and Bassetti, Matteo and SánchezGarcía, Miguel and Capparella, Maria Rita and Simoneau, Damien and Bodmann, Klaus Friedrich
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2013, Volume 68, Issue 2, pp. ii45 - ii55
Antimicrobial drug resistance is a growing problem in Europe and, even with differences in epidemiology, it is of great concern. The treatment of complicated... 
Complicated skin and soft-tissue infections | Complicated intra-abdominal infections | Non-interventional studies | Broad-spectrum antibacterial therapy | Polymicrobial infections | INFECTIOUS DISEASES | non-interventional studies | complicated skin and soft-tissue infections | ESCHERICHIA-COLI | MICROBIOLOGY | broad-spectrum antibacterial therapy | IN-VITRO SUSCEPTIBILITY | polymicrobial infections | complicated intra-abdominal infections | SEVERELY ILL PATIENTS | METALLO-BETA-LACTAMASE | SKIN-STRUCTURE INFECTIONS | INTENSIVE-CARE-UNIT | COMPLICATED INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Minocycline - pharmacology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Male | Skin Diseases, Bacterial - drug therapy | Gram-Negative Bacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Minocycline - therapeutic use | Aged, 80 and over | Adult | Female | Soft Tissue Infections - drug therapy | Bacterial Infections - microbiology | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Europe | Treatment Outcome | Soft Tissue Infections - epidemiology | Intraabdominal Infections - epidemiology | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Soft Tissue Infections - microbiology | Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Aged | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Pathogens | Effectiveness | Antibiotics | Antimicrobial agents | Drug resistance | Drug therapy | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Identification and Validation of Risk Factors for Postoperative Infectious Complications Following Hepatectomy
by Pessaux, P and van den Broek, M.A and Wu, T and Olde Damink, S and Piardi, T and Dejong, C.H.C and Ntourakis, D and van Dam, R.M
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 01/2013, Volume 17, Issue 11, pp. 1907 - 1916
Postoperative infectious complications (PICs) are associated with significant morbidity after abdominal surgery. Using multivariate analysis of data from a... 
Prevention | Medicine & Public Health | Surgery | Gastroenterology | Postoperative infectious complications | Risk factor | Hepatectomy | Predictive score | SURGERY | MAJOR LIVER RESECTION | MANAGEMENT | ACQUIRED PNEUMONIA | LONG-TERM SURVIVAL | GUIDELINES | CLASSIFICATION | HEPATIC RESECTION | SURGICAL SITE INFECTION | GASTROENTEROLOGY & HEPATOLOGY | NASOGASTRIC DECOMPRESSION | Humans | Middle Aged | Male | Blood Transfusion | Intubation, Gastrointestinal | Aged, 80 and over | Adult | Female | Catheter-Related Infections - epidemiology | Length of Stay | Surgical Wound Infection - epidemiology | Central Venous Catheters | Pneumonia - epidemiology | Risk Factors | Sepsis - epidemiology | Postoperative Complications - epidemiology | Portal Vein - surgery | Surgical Wound Infection - etiology | Biliary Tract | Intraabdominal Infections - epidemiology | Drainage | Urinary Tract Infections - epidemiology | Atrial Fibrillation - epidemiology | Diabetes Mellitus - epidemiology | Liver Diseases - surgery | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance Trial
by Bertrand, Xavier, PharmD, PhD and Dowzicky, Michael J., MS
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 1, pp. 124 - 137
Abstract Background The Tigecycline Evaluation and Surveillance Trial is an antimicrobial susceptibility surveillance program that collects gram-positive and... 
Internal Medicine | Medical Education | antimicrobial | gram-negative bacteria | ICU | surveillance | resistance | Antimicrobial | Resistance | Gram-negative bacteria | Surveillance | WORLDWIDE | RESISTANCE TRENDS | PHARMACOLOGY & PHARMACY | OUTCOMES | SMART | INTRAABDOMINAL INFECTIONS | Africa - epidemiology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Male | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Young Adult | Time Factors | Minocycline - therapeutic use | Adult | Female | Latin America - epidemiology | Anti-Infective Agents - therapeutic use | Europe - epidemiology | Gram-Negative Bacterial Infections - drug therapy | Gram-Negative Bacteria - drug effects | Middle East - epidemiology | Asia - epidemiology | Adolescent | Gram-Negative Bacteria - pathogenicity | Gram-Negative Bacterial Infections - epidemiology | Aged | North America - epidemiology | Intensive care | Infections | Antibiotics | Microbiology | Index Medicus | Life Sciences | Microbiology and Parasitology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Antimicrobial susceptibilities of aerobic and facultative Gram-negative bacilli from intra-abdominal infections in patients from seven regions in China in 2012 and 2013
by Zhang, Hui and Yang, Qiwen and Liao, Kang and Ni, Yuxing and Yu, Yunsong and Hu, Bijie and Sun, Ziyong and Huang, Wenxiang and Wang, Yong and Wu, Anhua and Feng, Xianju and Luo, Yanping and Hu, Zhidong and Chu, Yunzhuo and Chen, Shulan and Cao, Bin and Su, Jianrong and Gui, Bingdong and Duan, Qiong and Zhang, Shufang and Shao, Haifeng and Kong, Haishen and Badal, Robert E and Xu, Yingchun
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 245 - 251
To evaluate the antimicrobial susceptibility of Gram-negative bacilli that caused hospital-acquired and community-acquired intra-abdominal infections (IAIs) in... 
BACTERIA | AMERICA | MANAGEMENT | GUIDELINES | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | EMPIRIC ANTIBIOTIC-THERAPY | BETA-LACTAMASES | SEPSIS | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Enterobacteriaceae - enzymology | Humans | Sulbactam - pharmacology | Enterobacteriaceae - isolation & purification | Levofloxacin - pharmacology | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Piperacillin - pharmacology | beta-Lactamases - genetics | Ampicillin - pharmacology | beta-Lactamases - metabolism | Penicillanic Acid - analogs & derivatives | Cross Infection - epidemiology | Penicillanic Acid - pharmacology | Gene Expression | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Ciprofloxacin - pharmacology | Enterobacteriaceae - genetics | China - epidemiology | Amikacin - pharmacology | Cross Infection - drug therapy | Imipenem - pharmacology | Intraabdominal Infections - epidemiology | beta-Lactams - pharmacology | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Intraabdominal Infections - drug therapy | Community-Acquired Infections | Enterobacteriaceae Infections - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights